Legal & General Group’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.34M | Buy |
57,919
+5,752
| +11% | +$331K | ﹤0.01% | 1742 |
|
2025
Q1 | $3.04M | Buy |
52,167
+2,196
| +4% | +$128K | ﹤0.01% | 1757 |
|
2024
Q4 | $4.02M | Buy |
49,971
+1,080
| +2% | +$87K | ﹤0.01% | 1686 |
|
2024
Q3 | $3.92M | Buy |
48,891
+3,839
| +9% | +$308K | ﹤0.01% | 1684 |
|
2024
Q2 | $2.75M | Buy |
45,052
+299
| +0.7% | +$18.3K | ﹤0.01% | 1798 |
|
2024
Q1 | $2.21M | Buy |
44,753
+1,172
| +3% | +$57.9K | ﹤0.01% | 1899 |
|
2023
Q4 | $1.83M | Buy |
43,581
+5,114
| +13% | +$214K | ﹤0.01% | 1995 |
|
2023
Q3 | $1.26M | Buy |
38,467
+4,611
| +14% | +$151K | ﹤0.01% | 2103 |
|
2023
Q2 | $1.2M | Buy |
33,856
+26,796
| +380% | +$947K | ﹤0.01% | 2147 |
|
2023
Q1 | $201K | Buy |
7,060
+217
| +3% | +$6.16K | ﹤0.01% | 2590 |
|
2022
Q4 | $284K | Buy |
6,843
+295
| +5% | +$12.3K | ﹤0.01% | 2485 |
|
2022
Q3 | $271K | Sell |
6,548
-2,747
| -30% | -$114K | ﹤0.01% | 2510 |
|
2022
Q2 | $304K | Buy |
9,295
+8,585
| +1,209% | +$281K | ﹤0.01% | 2491 |
|
2022
Q1 | $25K | Hold |
710
| – | – | ﹤0.01% | 3178 |
|
2021
Q4 | $18K | Buy |
+710
| New | +$18K | ﹤0.01% | 3311 |
|